Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
SCHILLER AG
AMPRONIX

MR Software Designed for Improved Cardiac Exam Processing

By Medimaging International staff writers
Posted on 26 Feb 2013
New cardiac magnetic resonance imaging (MRI) software provides intuitive, rapid, semiautomatic analysis of basic cardiac parameters, allowing the user to create a comprehensive cardiac patient report within a streamlined clinical environment.

GE Healthcare’s (Chalfont St. Giles, UK) two new software packages for advanced analysis of cardiovascular magnetic resonance (MR) images are called the CardiacVX and MR VesselIQ Xpress. Both CardiacVX and MR VesselIQ Xpress were featured in the GE Healthcare booth at the annual meeting of the Society for Cardiac Magnetic Resonance (SCMR) on February 1-2, 2013, in San Francisco, CA, USA.

Cardiac MR can provide a large amount of data about the patient’s cardiac condition such as functional parameters, flow, and infarction. However, extricating this information and presenting it in an integrated fashion to the referring physician can be a time-consuming task for the technologist or clinician performing the study.

The US Food and Drug Administration (FDA) 510(k)-cleared CardiacVX runs on GE Healthcare’s Advantage workstation (AW), and provides a range of reproducible tools for rapid reviewing and reporting. CardiacVX performs, for instance, fast left ventricle segmentation and volumetric functional analysis in just two clicks. Additional tools include myocardial infarct evaluation, flow analysis (with Qp/Qs ratio), time-course analysis, iron-overload assessment, patent foramen ovale (PFO) assessment, and one-click customizable reporting macros, all within an intuitive, guided user interface.
“CardiacVX was designed to address the clinical demand for a more automated and user-friendly cardiac postprocessing tool to allow clinicians to quickly and easily arrive at needed diagnostic information,” said Anja Brau, PhD, manager of global cardiac MR applications for GE Healthcare.

Computed tomography (CT) angiography has been widely used for evaluating vascular stenosis or abnormalities, but even more, MR angiography is used because of the absence of radiation and calcium-blooming artifacts. Being able to use similar analysis workflow between CT and MR can greatly improve the clinician’s diagnostic efficiency. MR VesselIQ Xpress, built based on GE Healthcare’s CT VesselIQ Xpress platform, is an enhanced image analysis package for MR angiographic data to effectively analyze selected vessels for stenosis, directional tortuosity, and other vascular disorders. MR VesselIQ Xpress provides sophisticated applications such as automatic vessel tracking with centerline display of any vessel, fast three-dimensional (3D) visualization, and fast access to vessel cross section and profile images.

Moreover, MR VesselIQ Xpress automatically provides size, stenosis, and length measurements of abnormal anatomic structures with two deposited points. Measurement tables and associated images are taken and ready to be included in reports. This software was developed to aid radiologists and other clinicians in the effective assessment of vascular anatomy and disease.

CardiacVX and MR VesselIQ Xpress software packages run on GE’s AW and are compatible with AW releases 4.4, 4.5, and 4.6.

Related Links:
GE Healthcare


RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.